News Sentiment

IVA sentiment intelligence

Inventiva Sa news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 53 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 4.30 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

75/100 classification confidence.

Company focus 44

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+10.0% over one week, +11.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Positive

Inventiva (ENXTPA:IVA) Refreshes Its Board, Is The 62% Discount Too Wide?

Market Reaction

Price moving ahead of tone

61/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 75/100 classification
One-week reaction 10.0% Price confirming higher
Trend fit Trend inactive 11.7% over four weeks
Fair value 12.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 37
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 44
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
TradingView 12
Stock Titan 5
TradingKey 4
Idéal Investisseur 2
GlobeNewswire 2
ChartMill 2
Seeking Alpha 2

Event Lens

What the news is about

Classified themes
Market update 21
Earnings 18
Analyst action 7
Balance sheet 3
Guidance 2
Capital return 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-53 of 53
TradingKey Direct company coverage

Inventiva SA (IVA) Institutional Confidence

This article from TradingKey provides an overview of Inventiva SA's (IVA) institutional confidence, detailing significant shareholders and their recent activity. Key institutional holders include Samsara BioCapital, Paradigm BioCapital Advisors, and Deep Track Capital, with notab

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:10
Source
TradingKey
TradingKey Direct company coverage

Inventiva SA (IVA) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Inventiva SA (IVA), identifying major individual and institutional holders. It provides a breakdown of shareholders by type (e.g., Hedge Fund, Venture Capital) and tracks changes in institutional shareholding over recent quarters.

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 18:09
Source
TradingKey
TradingKey Direct company coverage

Inventiva SA (IVA) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Inventiva SA (IVA) stock information, focusing on its dividend and stock split history. It states that Inventiva SA has not distributed any dividends over the past five years and has no recorded stock split data. The page also displays current

Tone
Neutral 50/100
Event
Capital return
Published
17 Jun 2026 18:09
Source
TradingKey
Yahoo! Finance Canada Direct company coverage

Claret Capital Partners participates in €130m financing for Inventiva to support Phase 3 development

Claret Capital Partners has participated in a €130 million financing round for Inventiva, a biopharmaceutical company developing an oral treatment for chronic liver disease, MASH. Claret is providing €43 million of growth funding to support Inventiva's lanifibranor, currently in

Tone
Positive 75/100
Event
Market update
Published
16 Jun 2026 08:40
Source
Yahoo! Finance Canada